Analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020 | Public Health BMC

  • Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Patterns of cancer incidence and mortality in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018; 103: 356–87.

    CAS
    Article – Commodity

    Google Scholar

  • Wojtyla C, Bertuccio P, Wojtyla A, La Vecchia C. European trends in breast cancer mortality, 1980-2017 and predictions to 2025. Eur J Cancer. 2021; 152: 4-17.

    Article – Commodity

    Google Scholar

  • Bertuccio P, Santucci C, Carioli G, Malvezzi M, La Vecchia C, Negri E. Mortality trends from urinary tract cancers in Europe during 1980-2017 and a projection to 2025. Eur Urol Oncol. 2021; 4 (5): 677-96.

    Article – Commodity

    Google Scholar

  • Sebuødegård S, Botteri E, Hofvind S. Breast cancer mortality after implementation of population-based structured breast cancer screening in Norway. J Natl Cancer Inst 2020; 112 (8): 839–846. Errors in: J Natl Cancer Inst 2020; 112 (10): 1072–107.

  • Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality in Europe. chest. 2017; 36: 89-95.

    Article – Commodity

    Google Scholar

  • Kvåle R, Myklebust TA, Engholm G, Heinävaara S, Wist E, Møller B. Prostate and breast cancer in four Nordic countries: comparison of incidence and mortality trends across countries and age groups 1975–2013. Int J Cancer. 2017; 141: 2228–42.

    Article – Commodity

    Google Scholar

  • López-Abente G, Mispireta S, Pollán M. Breast and prostate cancer: analysis of common epidemiological features in mortality trends in Spain. BMC cancer. 2014; 14: 874.

    Article – Commodity

    Google Scholar

  • Welch HG, Albertsen PC. Prostate cancer mortality revisited–the future of PSA screening. In Engel J Med. 2020; 382 (16): 1557–63.

    Article – Commodity

    Google Scholar

  • Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N et al. European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021; 157: 308-47.

    Article – Commodity

    Google Scholar

  • Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality. Euro Urol. 2020; 77 (1): 38-52.

    Article – Commodity

    Google Scholar

  • Gondos A, Krilaviciute A, Smailyte G, Ulys A, Brenner H. Cancer surveillance using registry data: findings and recommendations for the Lithuanian National Prostate Cancer Early Detection Program. Eur J Cancer. 2015; 51 (12): 1630–167.

    Article – Commodity

    Google Scholar

  • Lopez Otten C, Diamandis Eb. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical characteristics. Endocer Reef. 199; 19 (4): 365–96.

    Article – Commodity

    Google Scholar

  • National Health Insurance Fund of the Lithuanian Ministry of Health. Breast cancer screening program performance in Lithuania in 2019. Available from: https://ligoniukasa.lrv.lt/uploads/ligoniukasa/documents/files/Veiklos_sritys/Ligu_prevencijos_programos/0324%202019%20patikros%20d%C4%97l%20kr%20v%C4%97%C5%BEio%. Accessed Jan. 18, 2022. In Lithuanian.

  • Ponti A, Anttila A, Ronco G, Senore C, Basu P, Segnan N, Tomatis M, Žakelj MP, Dillner J, Fernan M, Elfström KM, Lönnberg S, Soerjomataram I, Vale D. Cancer screening in the European Union. Report on the implementation of the Council’s recommendation on cancer screening. Lyon: International Agency for Research on Cancer, 2017. 313.

  • Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J et al. Prostate cancer incidence in 43 population groups worldwide: analysis of temporal trends generally and by age group. Int J Cancer. 2016; 138: 1388 – 400.

    CAS
    Article – Commodity

    Google Scholar

  • Innos K, Baburin A, Kotsar A, Eiche IE, Lang K. Trends in prostate cancer incidence, mortality, and survival in Estonia, 1995–2014. Scand j urol. 2017; 51 (6): 442-9.

    Article – Commodity

    Google Scholar

  • Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V et al. 16-year follow-up of the European Randomized Study for Prostate Cancer Screening. Euro Urol. 2019; 76: 43-51.

    Article – Commodity

    Google Scholar

  • Van Poppel H, Roobol MJ, Chapple CR, Catto JWF, N’Dow J, Sønksen J et al. Prostate-specific antigen testing as part of a risk-adapted prostate cancer early detection strategy: position and recommendations of the European Society of Urology 2021. Eur Urol. 2021; 80 (6): 703–11.

    Article – Commodity

    Google Scholar

  • Elek D, Gulbegovic M, Young JH, Hwang EC, Chu Qiu, Cliffs A, et al. Prostate cancer screening using the prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018; 5 (362): k3519. https://doi.org/10.1136/bmj.k3519.

    Article – Commodity

    Google Scholar

  • Council of the European Union Recommendation on Cancer Screening of 2 December 2003. (2003/878/EC). Official Journal of the European Union 16.12.2003. https://ec.europa.eu/jrc/sites/default/files/2_December_2003%20cancer%20screening.pdf. Accessed October 26, 2021.

  • Mott N, Kornford B, Van den Berg RCN, Briers E, De Santis M, Gillesen S, Grommet G, Henry AM, Van der Quast TH, LTP, Mason MD, O’Hanlon S, Opera Lager de, Plossard J., van der Poel HG, Rouvière O, Schoots IG, Tilki D, Wiegel T, van den Broeck T, Cumberbatch M, Farolfi A, Fossati N, Gandaglia G, Grivas N, Lardas M, Liew M, Moris L, Willemse PP. M. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Arnhem, Netherlands: European Urological Association, 2021. https://uroweb.org/wp-content/uploads/EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2021V3.pdf. Accessed January 18, 2022.

  • Van Poppel H, Hogenhout R, Albers P, van den Bergh RCN, Barentsz JO, Roobol MJ. A European model for a stratified staged early detection program for prostate cancer. Eur Urol Oncol. 2021; 4 (5): 731-9.

    Article – Commodity

    Google Scholar

  • European Code for Cancer Control. International Agency for Research on Cancer. https://cancer-code-europe.iarc.fr/index.php/en/ecac-12-ways. Accessed January 18, 2022.

  • Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M et al. STHLM3 Consortium. Targeted or standard biopsy in prostate cancer screening. In Engel J Med. 2021; 385 (10): 908-20.

    Article – Commodity

    Google Scholar

  • National Health Insurance Fund of the Lithuanian Ministry of Health. Prostate cancer screening program performance in Lithuania in 2019. Available from: https://ligoniukasa. 20diagnostikos%20programos%20ataskaita.pdf. Accessed Jan. 18, 2022. In Lithuanian.

  • Everatt R, Kuzmickienė I, Intaitė B, Anttila A. Effectiveness of a cervical cancer prevention programme: a mortality audit in Lithuania. Eur J Ex Cancer. 2020; 29 (6): 504-10.

    Article – Commodity

    Google Scholar

  • World Health Organization database. https://www.who.int/data/data-collection-tools/who-mortality-database. Accessed March 24, 2022.

  • Statistics Lithuania. https://osp.stat.gov.lt/statistiniu-rodikliu-analize#/. Accessed January 18, 2022.

  • National Cancer Institute Joinpoint Regression Program version 4.5.0.1 June: National Cancer Institute, Bethesda (MD), 2017. https://surveillance.cancer.gov/joinpoint/.

  • Rosenberg PS, Check DP, Anderson WF. A web-based tool for age-cohort analysis of cancer incidence and mortality. Cancer Epidemiol Ex-Biomark 2014; 23(11): 2296–2302. https://doi.org/10.1158/1055-9965.EPI-14-0300.

  • Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Héry C, et al. Disparities in breast cancer mortality trends among 30 European countries: a retrospective trend analysis of the WHO mortality database. BMJ. 2010; 341: c3620.

    Article – Commodity

    Google Scholar

  • Malvezzi M, Carioli G, Bertuccio P, Negri E, La Vecchia C. Relationship between mortality trends for cardiovascular disease and selected cancer types in the European Union, in 1970-2017. Focus on cohort and cycle effects. Eur J Cancer. 2018; 103: 341-55.

    CAS
    Article – Commodity

    Google Scholar

  • Grabauskas V, Klumbienė J, Petkevičienė J, Šakytė E, Kriaučionienė V, Veryga V. Health behavior among the Lithuanian adult population, 2014. Kaunas: Lithuanian University of Health Sciences, 2015. 146.

  • Grabauskas V, Klumbienė J, Petkevičienė J, Dregval L. Čepaitis Ž, Nedzelskien I, Puska P, Uutela A, Helakorpi S. Health behavior among the Lithuanian adult population, 1994. Kaunas Medical Academy, Lithuania. Helsinki: National Institute of Public Health, 1997.

  • The World Bank Group, 2022. https://data.worldbank.org/indicator/SP.DYN.CONU.ZS?locations=LT. Accessed January 20, 2022.

  • Steponaviciene L, Briediene R, Vanseviciute R, Smailyte G. Trends in breast cancer incidence and stage distribution before and during the introduction of a mammography screening program in Lithuania. Anti-cancer. 2019; 26 (1): 1073274818821096. https://doi.org/10.1177/1073274818821096.

    Article – Commodity
    PubMed
    PubMed Central

    Google Scholar

  • Duggan C, Trapani D, Ilbawi AM, Fidarova E, Laversanne M, Curigliano G et al. National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncol. 2021; 22 (11): 1632–1642. https://doi.org/10.1016/S1470-2045(21)00462-9.

    Article – Commodity
    PubMed

    Google Scholar

  • Héry C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 Caucasian-majority countries. Ann Oncol. 2008; 19 (6): 1187–1194.

    Article – Commodity

    Google Scholar

  • Adliene D, Adlys G, Cerapaite R, Jonaitiene E, Cibulskaite I. Improving X-ray examinations in Lithuania: roll-out in mammography. Brut Ducem Redbacks. 2005; 114 (1-3): 399-402. https://doi.org/10.1093/rpd/nch520.

    Article – Commodity

    Google Scholar

  • Grabauskas VJ, Klumbienė J, Petkevičienė J, Katvickis A, Šačkutė A, Helasoja V, et al. Prättälä Ritva. Health Behavior among the Lithuanian Adult Population, 2004. Helsinki: National Institute of Public Health; 2005. p. 164.

    Google Scholar

  • Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O et al. International variance in prostate cancer incidence and mortality rates. Euro Urol. 2012; 61 (6): 1079-1092.

    Article – Commodity

    Google Scholar

  • Feuer EJ, Merrill RM, Hankey BF. Cancer Surveillance Series: Interpreting trends in prostate cancer – Part II: The cause of mortality misclassification and the recent rise and fall in prostate cancer mortality. Cancer Institute Natel J. 1999; 91 (12): 1025–1032.

  • Patasius A, Krilaviciute A, Smailyte G. Prostate cancer screening using PSA: ten years’ experience in a population-based prostate cancer early detection program in Lithuania. J Clin Med. 2020; 9 (12): 3826.

    Article – Commodity

    Google Scholar

  • Seikkula HA, Kaipia AJ, Ryynänen H, Seppä K, Pitkäniemi JM, Malila NK et al. Impact of socioeconomic status on stage-specific prostate cancer survival and mortality before and after the introduction of the PSA test in Finland. Int J Cancer. 2018; 142 (5): 891-8.

    CAS
    Article – Commodity

    Google Scholar

  • Shwag Ji, Niam Ya, Gulati R, Etzioni R, Ho JC. Revisiting the trade-offs of prostate cancer screening. In Engel J Med. 2020; 382 (25): 2465–8.

    Article – Commodity

    Google Scholar